Corbus Pharmaceuticals Holdings logo
Corbus Pharmaceuticals Holdings CRBP
$ 10.41 -5.36%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Corbus Pharmaceuticals Holdings Balance Sheet 2011-2024 | CRBP

Annual Balance Sheet Corbus Pharmaceuticals Holdings

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

263 K -8.23 M -66.7 M -22.3 M -41.4 M -62.2 M -14.7 M -12.2 M -6.12 M 335 K - -

Long Term Debt

- 16 M 15.6 M 18 M - - - - - - 331 K - -

Long Term Debt Current

1.44 M 1.28 M 1.14 M 1 M 596 K - - - - - - - -

Total Non Current Liabilities

- - - 25.1 M 8.1 M 1.38 M 990 K 70.4 K 260 K - 1.44 M - -

Total Current Liabilities

31.9 M 12.6 M 17 M 31.9 M 34.9 M 18.1 M 8.2 M 8.9 M 3.63 M 738 K - - -

Total Liabilities

35.2 M 33.3 M 38.6 M 57 M 43 M 19.5 M 9.19 M 8.97 M 3.89 M 738 K 2.09 M - -

Deferred Revenue

- - - - - 1.46 M - 1.94 M 1.59 M - - - -

Retained Earnings

-437 M -392 M -350 M -304 M -193 M -121 M -65.7 M -33.3 M -13.3 M -4.43 M -1.89 M - -

Total Assets

28.3 M 66.3 M 108 M 102 M 49.1 M 47 M 67 M 17.9 M 12.9 M 6.6 M 306 K - -

Cash and Cash Equivalents

13.7 M 17 M 25 M 85.4 M 31.7 M 41.7 M 62.5 M 15 M 12.3 M 6.26 M 303 K - -

Book Value

-6.9 M 33 M 69.1 M 45.3 M 6.16 M 27.5 M 57.8 M 8.92 M 8.99 M 5.86 M -1.78 M - -

Total Shareholders Equity

-6.9 M 33 M 69.1 M 45.3 M 6.16 M 27.5 M 57.8 M 8.92 M 8.99 M 5.86 M -1.78 M - -

All numbers in USD currency

Quarterly Balance Sheet Corbus Pharmaceuticals Holdings

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

2.05 M 2.46 M - 3.24 M - 11.3 M 14 M 16 M 9.39 M 11.6 M 13.7 M 15.6 M 18.6 M 18.4 M 18.2 M 18 M 18 M 18 M 18 M 8.1 M 8.1 M 8.1 M 8.1 M 1.38 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

13.7 M 26.4 M 28.8 M 35.2 M 36 M 34.2 M 35.2 M 33.3 M 31.9 M 32.6 M 34.5 M 38.6 M 41.9 M 43.6 M 48.6 M 57 M 57 M 57 M 57 M 43 M 43 M 43 M 43 M 19.5 M 19.5 M 19.5 M 19.5 M 9.19 M 9.19 M 9.19 M 9.19 M 8.97 M 8.97 M 8.97 M 8.97 M 3.89 M 3.89 M 3.89 M 3.89 M 738 K 738 K 594 K 738 K 980 K 980 K - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - 271 K - - - 2.48 M 27 M 1.46 M 1.46 M 4.48 M 1.46 M - - 296 K 646 K 1.94 M 1.94 M 1.94 M 1.94 M 1.59 M 1.59 M 1.59 M 1.59 M - - - - - - - - - - - - - - - -

Retained Earnings

-467 M -454 M -444 M -437 M -429 M -419 M -410 M -392 M -381 M -372 M -359 M -350 M -339 M -337 M -320 M -304 M -304 M -304 M -304 M -193 M -193 M -193 M -193 M -121 M -121 M -121 M -121 M -65.7 M -65.7 M -65.7 M -65.7 M -33.3 M -33.3 M -33.3 M -33.3 M -13.3 M -13.3 M -13.3 M -13.3 M -4.43 M -4.43 M -4.43 M -4.43 M -1.89 M -1.89 M - - - - - - - - - -

Total Assets

164 M 152 M 126 M 28.3 M 36.3 M 43.7 M 51.6 M 66.3 M 73.8 M 82.1 M 95.7 M 108 M 120 M 121 M 140 M 102 M 102 M 102 M 102 M 49.1 M 49.1 M 49.1 M 49.1 M 47 M 47 M 47 M 47 M 67 M 67 M 67 M 67 M 17.9 M 17.9 M 17.9 M 17.9 M 12.9 M 12.9 M 12.9 M 12.9 M 6.6 M 6.6 M 6.6 M 6.6 M 306 K 306 K - - - - - - - - - -

Cash and Cash Equivalents

19.4 M 23.7 M 14.1 M 13.7 M 11.2 M 8.35 M 7.32 M 17 M 12.4 M 25.8 M 57 M 25 M 37.1 M 36.1 M 66.6 M 85.4 M 85.4 M 85.4 M 85.4 M 31.7 M 31.7 M 31.7 M 31.7 M 41.7 M 41.7 M 41.7 M 41.7 M 62.5 M 62.5 M 62.5 M 62.5 M 15 M 15 M 15 M 15 M 12.3 M 12.3 M 12.3 M 12.3 M 6.26 M 6.26 M 6.26 M 6.26 M 303 K 303 K - - 542 K - - - - - - -

Book Value

150 M 126 M 97 M -6.9 M 311 K 9.52 M 16.5 M 33 M 41.9 M 49.5 M 61.2 M 69.1 M 77.6 M 77 M 91.5 M 45.3 M 45.3 M 45.3 M 45.3 M 6.16 M 6.16 M 6.16 M 6.16 M 27.5 M 27.5 M 27.5 M 27.5 M 57.8 M 57.8 M 57.8 M 57.8 M 8.92 M 8.92 M 8.92 M 8.92 M 8.99 M 8.99 M 8.99 M 8.99 M 5.86 M 5.86 M 6.01 M 5.86 M -675 K -675 K - - - - - - - - - -

Total Shareholders Equity

150 M 126 M 97 M -6.9 M 312 K 9.52 M 16.5 M 33 M 41.9 M 49.5 M 61.2 M 69.1 M 77.6 M 77 M 91.5 M 45.3 M 45.3 M 45.3 M 45.3 M 6.16 M 6.16 M 6.16 M 6.16 M 27.5 M 27.5 M 27.5 M 27.5 M 57.8 M 57.8 M 57.8 M 57.8 M 8.92 M 8.92 M 8.92 M 8.92 M 8.99 M 8.99 M 8.99 M 8.99 M 5.86 M 5.86 M 5.86 M 5.86 M -1.78 M -1.78 M - - -1.19 M - - - - - - -

All numbers in USD currency